Cefditoren Pregnancy and Breastfeeding Warnings
Brand names: Spectracef
Cefditoren Pregnancy Warnings
Cefditoren pivoxil has been assigned to pregnancy category B by the FDA. High-dose animal studies have not revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Cefditoren pivoxil is only recommended for use during pregnancy when benefit outweighs risk.
Cefditoren Breastfeeding Warnings
There are no data on the excretion of cefditoren into human milk. Cefditoren is excreted into the milk of rats. The manufacturer recommends caution when cefditoren pivoxil is given to nursing women. The American Academy of Pediatrics classifies other cephalosporins as compatible with breast-feeding.
See also
References for pregnancy information
- (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc
References for breastfeeding information
- Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins
- (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.